Delivery Order SPE2DB22D2206-SPE2DB25FJC47
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Neupogen 300 mcg/mL vials with a ceiling value of $2,429.58. This is a firm fixed price, competitive delivery order with no set-aside designation and a completion date of July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- This federal contract award is for the pharmaceutical product Neupogen 480 mcg/0.8 mL syringe, awarded to the prime contractor Amerisourcebergen Drug Corp. The $2,482.88 firm fixed price delivery order has an ultimate completion date of November 22, 2024. The contract was awarded on November 21, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency supplying medical products to military treatment facilities and veterans' healthcare programs. Amerisourcebergen, a...
- The Defense Logistics Agency Troop Support Medical awarded a $1,211.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 300 mcg/ml vials of the drug Neupogen. Performance will take place in Conshohocken, Pennsylvania from July 14-17, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical product to the Defense Logistics Agency under this small, short-term order to supply necessary medical supplies to troops. No...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty pharmaceutical product. The contract has a firm fixed price of $17,160.11 and a period of performance through November 14, 2024. Amerisourcebergen is a major pharmaceutical distribution and healthcare solutions provider, and this contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $5,200.48, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of January 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
- The U.S. Defense Logistics Agency awarded a Firm Fixed Price delivery order contract valued at $2,303.34 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NEUPOGEN 300 MCG/ML VIALML pharmaceutical products to support federal government medical requirements. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,595.11 for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), for the delivery of this pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and the contract is a firm fixed-price delivery...
- The Defense Logistics Agency awarded a $28,076.54 delivery order to AmerisourceBergen Drug Corp for Neulasta 6 mg/0.6 ml syringes on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,035.48 firm fixed price delivery order is for the supply of NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, a specialty medication, with a performance period through April 2025. The contract is not designated with a set-aside and represents open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery...